MRD Assessments
Detectable bone marrow MRD was present at diagnosis in 15/76 (19.7%) patients tested at a threshold of 0.01% and 13/79 (16.5%) at a threshold of 0.1%. The event-free (p=0.9332) and overall survival (p=0.9522) rates were superimposable for both MRD cut-offs (Figure 4 ).